Anorexia in human and experimental animal models: physiological aspects related to neuropeptides

Journal of Physiological Sciences

Volumn 65, Issue 5, 2015, Pages 385-395

  Yoshimura, Mitsuhiro ^a   Uezono, Yasuhito ^b   Ueta, Yoichi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Anorexia; Behavior; Feeding regulating neuropeptides; Hypothalamus; Rodents

Indexed keywords

CISPLATIN; NEUROPEPTIDE;

ANIMAL; ANIMAL BEHAVIOR; ANOREXIA; CACHEXIA; COMPLICATION; DEHYDRATION; DISEASE MODEL; FEEDING BEHAVIOR; HUMAN; HYPOTHALAMUS; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE;

ANIMALS; ANOREXIA; BEHAVIOR, ANIMAL; CACHEXIA; CISPLATIN; DEHYDRATION; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; HUMANS; HYPOTHALAMUS; NEOPLASMS; NEUROPEPTIDES; RISK FACTORS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 84940579413     PISSN: 18806546     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12576-015-0386-3     Document Type: Review

References (129)

1. Piccinni A, Marazziti D, Vanelli F, Franceschini C, Baroni S, Costanzo D, Cremone IM, Veltri A, Dell'Osso L (2015) Food addiction spectrum: a theoretical model from normality to eating and overeating disorders. Curr Med Chem 22(13):1631–1638
2. Lozano R et al (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2095–2128
3. Debons AF et al (1968) Gold thioglucose damage to the satiety center: inhibition in diabetes. Am J Physiol 214(3):652–658
4. Anand BK, Brobeck JR (1951) Localization of a feeding center in the hypothalamus of the rat. Proc Soc Exp Biol Med 77(2):323–324
5. Anand BK, Brobeck JR (1951) Hypothalamic control of food intake in rats and cats. Yale J Biol Med 24(2):123–140
6. Morgane PJ (1961) Evidence of a hunger motivational system in the lateral hypothalamus of the rat. Nature 191:672–674
7. Hoess RH, Ziese M, Sternberg N (1982) P1 site-specific recombination: nucleotide sequence of the recombining sites. Proc Natl Acad Sci USA 79(11):3398–3402
8. Wu Q, Clark MS, Palmiter RD (2012) Deciphering a neuronal circuit that mediates appetite. Nature 483(7391):594–597
9. Merali Z et al (2013) Stress and eating: a dual role for bombesin-like peptides. Front Neurosci 7:193
10. Yoshimura M et al (2014) A role of nesfatin-1/NucB2 in dehydration-induced anorexia. Am J Physiol Regul Integr Comp Physiol 307(2):R225–R236
11. Watts AG, Sanchez-Watts G, Kelly AB (1999) Distinct patterns of neuropeptide gene expression in the lateral hypothalamic area and arcuate nucleus are associated with dehydration-induced anorexia. J Neurosci 19(14):6111–6121
12. Haque Z et al (2013) Inhibition of immobilization stress-induced anorexia, behavioral deficits, and plasma corticosterone secretion by injected leptin in rats. Stress 16(3):353–362
13. Yoshimura M et al (2013) The gene expression of the hypothalamic feeding-regulating peptides in cisplatin-induced anorexic rats. Peptides 46:13–19
14. Lugarini F et al (2002) A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am J Physiol Regul Integr Comp Physiol 283(4):R862–R868
15. Terawaki K et al (2014) New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line. Am J Physiol Endocrinol Metab 306(4):E373–E387
16. Ueta Y et al (2007) Hypothalamic neuropeptides and appetite response in anorexia-cachexia animal. Endocr J 54(6):831–838
17. Cooper MJ (2005) Cognitive theory in anorexia nervosa and bulimia nervosa: progress, development and future directions. Clin Psychol Rev 25(4):511–531
18. Attia E (2010) Anorexia nervosa: current status and future directions. Annu Rev Med 61:425–435
19. Treasure J, Claudino AM, Zucker N (2010) Eating disorders. Lancet 375(9714):583–593
20. Pearce JM (2004) Richard Morton: origins of anorexia nervosa. Eur Neurol 52(4):191–192
21. Gull WW (1997) Anorexia nervosa (apepsia hysterica, anorexia hysterica). 1868. Obes Res 5(5):498–502
22. Smink FR, van Hoeken D, Hoek HW (2012) Epidemiology of eating disorders: incidence, prevalence and mortality rates. Curr Psychiatry Rep 14(4):406–414
23. Favaro A, Tenconi E, Santonastaso P (2006) Perinatal factors and the risk of developing anorexia nervosa and bulimia nervosa. Arch Gen Psychiatry 63(1):82–88
24. Wade TD et al (2000) Anorexia nervosa and major depression: shared genetic and environmental risk factors. Am J Psychiatry 157(3):469–471
25. Kaye WH et al (2005) Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behav 85(1):73–81
26. Frederich R et al (2002) Leptin in anorexia nervosa and bulimia nervosa: importance of assay technique and method of interpretation. J Lab Clin Med 139(2):72–79
27. Swedo SE et al (1998) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 155(2):264–271
28. Fetissov SO et al (2005) Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci USA 102(41):14865–14870
29. Shay NF, Mangian HF (2000) Neurobiology of zinc-influenced eating behavior. J Nutr 130(5S Suppl):1493S–1499S
30. Garner DM, Garfinkel PE (1980) Socio-cultural factors in the development of anorexia nervosa. Psychol Med 10(4):647–656
31. Zonnevijlle-Bender MJ et al (2002) Do adolescent anorexia nervosa patients have deficits in emotional functioning? Eur Child Adolesc Psychiatry 11(1):38–42
32. Harrison A et al (2009) Emotion recognition and regulation in anorexia nervosa. Clin Psychol Psychother 16(4):348–356
33. Lock JD, Fitzpatrick KK (2009) Anorexia nervosa. BMJ Clin Evid
34. Brambilla F et al (2007) Olanzapine therapy in anorexia nervosa: psychobiological effects. Int Clin Psychopharmacol 22(4):197–204
35. Halmi KA (1996) The psychobiology of eating behavior in anorexia nervosa. Psychiatry Res 62(1):23–29
36. Chronwall BM, Chase TN, O’Donohue TL (1984) Coexistence of neuropeptide Y and somatostatin in rat and human cortical and rat hypothalamic neurons. Neurosci Lett 52(3):213–217
37. Broberger C et al (1998) The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 95(25):15043–15048
38. Medina F et al (1998) The inter-relationship between gonadal steroids and POMC peptides, beta-endorphin and alpha-MSH, in the control of sexual behavior in the female rat. Peptides 19(8):1309–1316
39. Xin XG, Huang XF (1998) Down-regulated NPY receptor subtype-5 mRNA expression in genetically obese mouse brain. NeuroReport 9(4):737–741
40. Criscione L et al (1998) Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor. J Clin Invest 102(12):2136–2145
41. Schwartz MW et al (1996) Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98(5):1101–1106
42. Morgan DG et al (1998) Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells. Diabetologia 41(12):1482–1491
43. Nijenhuis WA, Oosterom J, Adan RA (2001) AgRP(83–132) acts as an inverse agonist on the human-melanocortin-4 receptor. Mol Endocrinol 15(1):164–171
44. Irani BG et al (2011) Implication of the melanocortin-3 receptor in the regulation of food intake. Eur J Pharmacol 660(1):80–87
45. Gropp E et al (2005) Agouti-related peptide-expressing neurons are mandatory for feeding. Nat Neurosci 8(10):1289–1291
46. Krashes MJ et al (2013) Rapid versus delayed stimulation of feeding by the endogenously released AgRP neuron mediators GABA, NPY, and AgRP. Cell Metab 18(4):588–595
47. Atasoy D et al (2012) Deconstruction of a neural circuit for hunger. Nature 488(7410):172–177
48. Krashes MJ et al (2014) An excitatory paraventricular nucleus to AgRP neuron circuit that drives hunger. Nature 507(7491):238–242
49. Kiss JZ et al (1985) Topographical distribution of pro-opiomelanocortin-derived peptides (ACTH/beta-END/alpha-MSH) in the rat median eminence. Brain Res 329(1–2):169–176
50. Sergeyev V, Broberger C, Hokfelt T (2001) Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Brain Res Mol Brain Res 90(2):93–100
51. Jureus A et al (2000) Galanin-like peptide (GALP) is a target for regulation by leptin in the hypothalamus of the rat. Endocrinology 141(7):2703–2706
52. Mercer JG et al (1996) Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 8(10):733–735
53. Hakansson ML, Meister B (1998) Transcription factor STAT3 in leptin target neurons of the rat hypothalamus. Neuroendocrinology 68(6):420–427
54. Funato H et al (2009) Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab 9(1):64–76
55. Sternson SM, Shepherd GM, Friedman JM (2005) Topographic mapping of VMH→arcuate nucleus microcircuits and their reorganization by fasting. Nat Neurosci 8(10):1356–1363
56. Gao Q et al (2007) Anorectic estrogen mimics leptin’s effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nat Med 13(1):89–94
57. Sakurai T et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92(5): p 1 page following 696
58. Kiwaki K et al (2004) Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocrinol Metab 286(4):E551–E559
59. Williamson-Hughes PS, Grove KL, Smith MS (2005) Melanin concentrating hormone (MCH): a novel neural pathway for regulation of GnRH neurons. Brain Res 1041(2):117–124
60. Shimada M et al (1998) Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396(6712):670–674
61. Hara J, Yanagisawa M, Sakurai T (2005) Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neurosci Lett 380(3):239–242
62. Fujiki N et al (2006) Sex difference in body weight gain and leptin signaling in hypocretin/orexin deficient mouse models. Peptides 27(9):2326–2331
63. Kampe J et al (2006) Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat. Brain Res 1119(1):133–149
64. Ramanjaneya M et al (2013) QRFP induces aldosterone production via PKC and T-type calcium channel-mediated pathways in human adrenocortical cells: evidence for a novel role of GPR103. Am J Physiol Endocrinol Metab 305(9):E1049–E1058
65. Primeaux SD (2011) QRFP in female rats: effects on high fat food intake and hypothalamic gene expression across the estrous cycle. Peptides 32(6):1270–1275
66. Primeaux SD, Barnes MJ, Braymer HD (2013) Hypothalamic QRFP: regulation of food intake and fat selection. Horm Metab Res 45(13):967–974
67. Bell ME et al (2000) Disruption of arcuate/paraventricular nucleus connections changes body energy balance and response to acute stress. J Neurosci 20(17):6707–6713
68. Solomon A, De Fanti BA, Martinez JA (2005) Peripheral ghrelin participates in glucostatic feeding mechanisms and in the anorexigenic signalling mediated by CART and CRF neurons. Nutr Neurosci 8(5–6):287–295
69. Siljee JE et al (2013) Melanocortin 4 receptor distribution in the human hypothalamus. Eur J Endocrinol 168(3):361–369
70. Vella KR et al (2011) NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways. Cell Metab 14(6):780–790
71. Balthasar N et al (2005) Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123(3):493–505
72. Juszczak M et al (2014) The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies. J Physiol Pharmacol 65(6):777–784
73. Morton GJ et al (2006) Central nervous system control of food intake and body weight. Nature 443(7109):289–295
74. Hagen TC, Guansing AR, Sill AJ (1976) Preliminary evidence for a human prolactin releasing factor. Neuroendocrinology 21(3):255–261
75. Lin MT, Chu PC, Leu SY (1983) Effects of TSH, TRH, LH and LHRH on thermoregulation and food and water intake in the rat. Neuroendocrinology 37(3):206–211
76. Steward CA et al (2003) Central administration of thyrotropin releasing hormone (TRH) and related peptides inhibits feeding behavior in the Siberian hamster. Neuroreport 14(5):687–691
77. Kow LM, Pfaff DW (1987) Neuropeptides TRH and cyclo(His-Pro) share neuromodulatory, but not stimulatory, action on hypothalamic neurons in vitro: implication for the regulation of feeding. Exp Brain Res 67(1):93–99
78. Oh IS et al (2006) Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443(7112):709–712
79. Stengel A, Tache Y (2011) Minireview: nesfatin-1—an emerging new player in the brain-gut, endocrine, and metabolic axis. Endocrinology 152(11):4033–4038
80. Maejima Y et al (2009) Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 10(5):355–365
81. Inhoff T et al (2008) Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides 29(12):2159–2168
82. Fort P et al (2008) The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience 155(1):174–181
83. Shimizu H et al (2009) A new anorexigenic protein, nesfatin-1. Peptides 30(5):995–998
84. King BM (2006) The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol Behav 87(2):221–244
85. Kim KW et al (2008) Steroidogenic factor 1 regulates expression of the cannabinoid receptor 1 in the ventromedial hypothalamic nucleus. Mol Endocrinol 22(8):1950–1961
86. Bodnar RJ (2013) Endogenous opiates and behavior: 2012. Peptides 50:55–95
87. Dhillon H et al (2006) Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron 49(2):191–203
88. Lu XY et al (2000) Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 37(4):335–344
89. Watts AG (1999) Dehydration-associated anorexia: development and rapid reversal. Physiol Behav 65(4–5):871–878
90. Watts AG (2001) Neuropeptides and the integration of motor responses to dehydration. Annu Rev Neurosci 24:357–384
91. Schoorlemmer GH, Evered MD (2002) Reduced feeding during water deprivation depends on hydration of the gut. Am J Physiol Regul Integr Comp Physiol 283(5):R1061–R1069
92. Boyle CN et al (2012) Dehydration-anorexia derives from a reduction in meal size, but not meal number. Physiol Behav 105(2):305–314
93. Watts AG, Boyle CN (2010) The functional architecture of dehydration-anorexia. Physiol Behav 100(5):472–477
94. Watts AG, Kelly AB, Sanchez-Watts G (1995) Neuropeptides and thirst: the temporal response of corticotropin-releasing hormone and neurotensin/neuromedin N gene expression in rat limbic forebrain neurons to drinking hypertonic saline. Behav Neurosci 109(6):1146–1157
95. Garcia-Luna C et al (2010) Prepro-orexin and feeding-related peptide receptor expression in dehydration-induced anorexia. Regul Pept 159(1–3):54–60
96. Alvarez-Salas E et al (2012) Food-restricted and dehydrated-induced anorexic rats present differential TRH expression in anterior and caudal PVN. Role of type 2 deiodinase and pyroglutamyl aminopeptidase II. Endocrinology 153(8):4067–4076
97. Jaimes-Hoy L, Joseph-Bravo P, de Gortari P (2008) Differential response of TRHergic neurons of the hypothalamic paraventricular nucleus (PVN) in female animals submitted to food-restriction or dehydration-induced anorexia and cold exposure. Horm Behav 53(2):366–377
98. Rinaman L et al (2005) Dehydration anorexia is attenuated in oxytocin-deficient mice. Am J Physiol Regul Integr Comp Physiol 288(6):R1791–R1799
99. Just N, Gruetter R (2011) Detection of neuronal activity and metabolism in a model of dehydration-induced anorexia in rats at 14.1 T using manganese-enhanced MRI and 1H MRS. NMR Biomed 24(10):1326–1336
100. Kocsis F, Klein W, Altmann H (1973) A screening system to determine inhibition of specific enzymes of the semiconservative DNA-synthesis and DNA-repair replication (author’s transl). Z Naturforsch C 28(3):131–135
101. du Percie Sert N et al (2011) Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT(3) receptor antagonists. Cancer Chemother Pharmacol 67(3):667–686
102. Yakabi K et al (2010) Reduced ghrelin secretion in the hypothalamus of rats due to cisplatin-induced anorexia. Endocrinology 151(8):3773–3782
103. Yakabi K et al (2010) Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction. Regul Pept 161(1–3):97–105
104. Voigt JP, Fink H (2015) Serotonin controlling feeding and satiety. Behav Brain Res 277:14–31
105. Nara-ashizawa N et al (2001) Hypothalamic appetite-regulating neuropeptide mRNA levels in cachectic nude mice bearing human tumor cells. Metabolism 50(10):1213–1219
106. Fujitsuka N, Uezono Y (2014) Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome. Front Pharmacol 5:271
107. Evans WJ et al (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799
108. Mondello P et al (2015) Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options. Nutr Cancer 67(1):12–26
109. Fearon K, Arends J, Baracos V (2013) Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10(2):90–99
110. Ramos EJ et al (2004) Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care 7(4):427–434
111. Laviano A et al (2005) Therapy insight: cancer anorexia-cachexia syndrome—when all you can eat is yourself. Nat Clin Pract Oncol 2(3):158–165
112. Muscaritoli M et al (2006) Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer 42(1):31–41
113. Jensen PB et al (1998) Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus. J Clin Invest 101(2):503–510
114. Chance WT et al (1998) NPY messenger RNA is increased in medial hypothalamus of anorectic tumor-bearing rats. Regul Pept 75–76:347–353
115. Bing C et al (2001) Cachexia in MAC16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y. J Neurochem 79(5):1004–1012
116. Plata-Salaman CR, Ilyin SE, Gayle D (1998) Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. Am J Physiol 275(2 Pt 2):R566–R573
117. Chance WT et al (1996) Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y. Peptides 17(5):797–801
118. McCarthy HD et al (1993) Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats. Am J Physiol 264(4 Pt 1):E638–E643
119. Nakhate KT et al (2010) Hypothalamic cocaine- and amphetamine-regulated transcript peptide is reduced and fails to modulate feeding behavior in rats with chemically-induced mammary carcinogenesis. Pharmacol Biochem Behav 97(2):340–349
120. Suzuki M et al (2012) Changes in the melanocortin receptors in the hypothalamus of a rat model of cancer cachexia. Synapse 66(8):747–751
121. Fujitsuka N et al (2011) Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Transl Psychiatry 1:e23
122. Grill V, Rankin W, Martin TJ (1998) Parathyroid hormone-related protein (PTHrP) and hypercalcaemia. Eur J Cancer 34(2):222–229
123. Suva LJ et al (1987) A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237(4817):893–896
124. Kukreja SC et al (1988) Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors. J Clin Invest 82(5):1798–1802
125. Iguchi H et al (2001) Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen. Int J Cancer 94(1):24–27
126. Onuma E et al (2005) Parathyroid hormone-related protein (PTHrP) as a causative factor of cancer-associated wasting: possible involvement of PTHrP in the repression of locomotor activity in rats bearing human tumor xenografts. Int J Cancer 116(3):471–478
127. Hashimoto H et al (2007) Parathyroid hormone-related protein induces cachectic syndromes without directly modulating the expression of hypothalamic feeding-regulating peptides. Clin Cancer Res 13(1):292–298
128. Kir S et al (2014) Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 513(7516):100–104
129. Weaver DR et al (1995) Localization of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor mRNAs in rat brain. Brain Res Mol Brain Res 28(2):296–310